» Articles » PMID: 33884523

Our Greatest Untapped Resource: Our Patients

Overview
Publisher Springer
Specialty Health Services
Date 2021 Apr 22
PMID 33884523
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Healthcare is continually evolving to meet the changing needs of twenty-first century populations whilst striving to keeping pace with medical and technological advancements. Patients and clinicians remain the constants in this evolving environment, sitting at the cutting edge of new evidence and innovation and at the coalface of clinical services which need to address the increasingly challenging health priorities we face as a society. Patients and clinicians, positioned centre stage in this changing world, must adjust their relationships and partnerships to reduce the burden of illness and ensure that multifaceted care needs are all properly addressed. In rare diseases, this relationship between patients and professionals demands a new model of care, in which patients are active, valued partners in their own care and function not as 'enlightened self-interested' individuals but as experts by experience. The unique characteristics of rare diseases demand that care evolves beyond multidisciplinary team care to 'Networked-care', in which care is prescribed based upon the body of experience and expertise of a community of experts and patients (who are experts by experience). Healthcare models are being redrawn around a new norm of clinical practice based on true patient-clinical partnerships in care. A partnership with patients, when supported by proper investment, is a collaborative relationship that aligns both the medical and clinical perspectives of professionals with a holistic perspective of patients' life experiences. Such partnerships can (i) ensure that decisions around care and design of services are needs-led, (ii) reduce the fog of uncertainty that surrounds rare diseases, (iii) amplify the success of new discoveries, and (iv) create breakthrough innovations: in these ways, patient-clinical partnerships increase the efficiency and effectiveness of our work and build a more sustainable future for our healthcare services.

Citing Articles

Hospital administrators as forgotten partners in rare disease care: a call to action by the international hospital federation's global rare pediatric disease network.

Stoesz A, Joers B, Gaviglio A Orphanet J Rare Dis. 2024; 19(1):456.

PMID: 39633381 PMC: 11616372. DOI: 10.1186/s13023-024-03459-5.


Conceptualizing Patient as an Organization With the Adoption of Digital Health.

Das Gupta A Biomed Eng Comput Biol. 2024; 15:11795972241277292.

PMID: 39324148 PMC: 11423387. DOI: 10.1177/11795972241277292.


European Achondroplasia Forum Practical Considerations for Following Adults with Achondroplasia.

Fredwall S, AlSayed M, Ben-Omran T, Boero S, Cormier-Daire V, Fauroux B Adv Ther. 2024; 41(7):2545-2558.

PMID: 38748332 PMC: 11213767. DOI: 10.1007/s12325-024-02880-3.


Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation.

McNiff M, Hawkins S, Haase B, Bullivant J, McIver T, Mitelman O J Neuromuscul Dis. 2024; 11(2):459-472.

PMID: 38277300 PMC: 10977383. DOI: 10.3233/JND-230171.


Rare diseases: still on the fringes of universal health coverage in Europe.

Tumiene B, Juozapaviciute A, Andriukaitis V Lancet Reg Health Eur. 2024; 37:100783.

PMID: 38169941 PMC: 10758954. DOI: 10.1016/j.lanepe.2023.100783.


References
1.
Coulter A, Ellins J . Effectiveness of strategies for informing, educating, and involving patients. BMJ. 2007; 335(7609):24-7. PMC: 1910640. DOI: 10.1136/bmj.39246.581169.80. View

2.
Lynn S, Hedley V, Atalaia A, Evangelista T, Bushby K . How the EUCERD Joint Action supported initiatives on Rare Diseases. Eur J Med Genet. 2017; 60(3):185-189. DOI: 10.1016/j.ejmg.2017.01.002. View

3.
Charmel P, Frampton S . Building the business case for patient-centered care. Healthc Financ Manage. 2008; 62(3):80-5. View

4.
Armstrong M, Daniel Mullins C, Gronseth G, Gagliardi A . Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients. PLoS One. 2017; 12(3):e0174329. PMC: 5358846. DOI: 10.1371/journal.pone.0174329. View

5.
Sharma A, Knox M, Mleczko V, Olayiwola J . The impact of patient advisors on healthcare outcomes: a systematic review. BMC Health Serv Res. 2017; 17(1):693. PMC: 5651621. DOI: 10.1186/s12913-017-2630-4. View